Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price
₹1,804.10
Market cap
₹4,32,864 Cr
Revenue (annual)
₹58,462 Cr
Net profit (annual)
₹11,479 Cr
P/E (TTM)
35.8×Sector 47.4×
Promoter holding
54.48%+0.00% QoQ
FII holding
14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

08:40 IST BSE
Regulatory Approval

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma received SAHPRA approval to market generic semaglutide in South Africa. This marks the company's second market approval for the diabetes treatment after India.